Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adaptimmune Therapeutics plc (ADAP)

0.856   0.039 (4.71%) 11-12 16:00
Open: 0.845 Pre. Close: 0.8175
High: 0.9054 Low: 0.824
Volume: 457,644 Market Cap: 90M
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.912 - 0.918 0.918 - 0.924
Low: 0.806 - 0.813 0.813 - 0.82
Close: 0.849 - 0.86 0.86 - 0.871

Technical analysis

as of: 2019-11-12 4:25:28 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.20     One year: 1.37
Support: Support1: 0.80    Support2: 0.67
Resistance: Resistance1: 1.03    Resistance2: 1.17
Pivot: 0.92
Moving Average: MA(5): 0.88     MA(20): 0.94
MA(100): 2.01     MA(250): 3.54
MACD: MACD(12,26): -0.10     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 12.04     %D(3): 15.73
RSI: RSI(14): 35.77
52-week: High: 6.55  Low: 0.80  Change(%): -85.7
Average Vol(K): 3-Month: 31543  10-Days: 33852

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ADAP has closed above bottom band by 28.6%. Bollinger Bands are 61.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADAP's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 25 Oct 2019 12:57:46 +0000
Healthcare Stocks On The Move (EW, NVO, BBI…)

Tue, 23 Apr 2019 14:42:58 +0000
European ADRs Move Lower in Tuesday Trading

Thu, 18 Aug 2016 15:35:52 +0000
European ADRs Edge Up Driven by Telecoms and Banks

Tue, 21 Jun 2016 14:57:13 +0000
European ADRs Edge Higher as Financial Services Stocks Rise, 3D Printer-Makers Post Mixed Fortunes

Wed, 03 Apr 2019 14:49:50 +0000
Correction: European ADRs Move Higher in Wednesday Trading

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 105.17
Shares Float (M) 53.21
% Held by Insiders 0.22
% Held by Institutions 73.00
Shares Short (K) 3770
Shares Short P. Month (K)

Stock Financials

EPS -1.375
Book Value (p.s.) 1.400
PEG Ratio -0.68
Profit Margin
Operating Margin -7555.85
Return on Assets (ttm) -34.2
Return on Equity (ttm) -67.9
Qtrly Rev. Growth -99.4
Gross Profit (p.s.) -0.369
Sales Per Share
EBITDA (p.s.) -1.269
Qtrly Earnings Growth
Operating Cash Flow (M) -131.66
Levered Free Cash Flow (M) -94.11

Stock Valuations

P/E -0.62
P/E Growth Ratio 0.05
P/BV 0.61
P/S 42.80
P/CF -0.68

Dividends & Splits

Dividend Yield
Dividend Pay Date 2018-03-30
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.